BioCentury | May 21, 2012
Company News

CryoLife, Hemosphere deal

...CryoLife acquired medical device company Hemosphere for $17 million in cash, plus up to $4.5 million...
...portfolio with higher-growth cardiac and vascular surgery medical devices, is expected to close this month. Hemosphere's...
...Oppenheimer Wolff & Donnelly LLP was legal advisor to Hemosphere. CryoLife Inc. (NYSE:CRY), Kennesaw, Ga. Hemosphere Inc....
BioCentury | Jun 19, 1995
Clinical News

Hemosphere Inc. preclinical data

...and forming a clot. An IND will be filed by the end of this year. Hemosphere Inc....
Items per page:
1 - 2 of 2
BioCentury | May 21, 2012
Company News

CryoLife, Hemosphere deal

...CryoLife acquired medical device company Hemosphere for $17 million in cash, plus up to $4.5 million...
...portfolio with higher-growth cardiac and vascular surgery medical devices, is expected to close this month. Hemosphere's...
...Oppenheimer Wolff & Donnelly LLP was legal advisor to Hemosphere. CryoLife Inc. (NYSE:CRY), Kennesaw, Ga. Hemosphere Inc....
BioCentury | Jun 19, 1995
Clinical News

Hemosphere Inc. preclinical data

...and forming a clot. An IND will be filed by the end of this year. Hemosphere Inc....
Items per page:
1 - 2 of 2